Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Temporal Trends in the Complexity of Nephrology Inpatients: A Population-Based Cohort Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026
Same author

Identification of Maintenance Dialysis Recipients From an Electronic Clinical Information System and Effects on Estimates of Incidence and Prevalence.

Kidney medicine·2026
Same author

Reply to Odo-Interpreting Trends in Cardiac Imaging Use Across Alberta.

The Canadian journal of cardiology·2026
Same author

A parallel private-pay system will worsen access to publicly funded surgery.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Ten-Year Anniversary of the Advisory Panel on Healthcare Innovation Report: Assessing Progress and What Is Left to Do.

HealthcarePapers·2026
Same journal

Alcohol-Related Liver Disease: A Review.

JAMA·2026
Same journal

Online Prescribing of GLP-1 Receptor Agonists.

JAMA·2026
Same journal

Using AI Disagreement to Expose Gaps in Coverage Rules.

JAMA·2026
Same journal

Randomized Trials in Pregnancy.

JAMA·2026
Same journal

Randomized Trials in Pregnancy-Reply.

JAMA·2026
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
関連記事をすべて見る

関連する実験動画

Updated: Jun 16, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

腎機能,タンパク質尿,有害な結果との関連

Brenda R Hemmelgarn1, Braden J Manns, Anita Lloyd

  • 1Department of Medicine, University of Calgary, Calgary, Alberta, Canada. brenda.hemmelgarn@albertahealthservices.ca

JAMA
|February 4, 2010
PubMed
まとめ
この要約は機械生成です。

タンパク質尿症は,正常な腎機能 (eGFR) にもかかわらず,死亡や腎不全などの有害な結果のリスクを大幅に増加させます. これは,よりよい患者管理のために,プロテイン尿を慢性腎疾患リスク評価に組み込む必要性を強調しています.

関連する実験動画

Last Updated: Jun 16, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

科学分野:

  • ネフロロジーはネフロロジーを用います.
  • 心臓病学 心臓病学
  • 公衆衛生は公衆衛生である.

背景:

  • 現在の慢性腎臓病 (CKD) の段階化は,推定されるグルメルフィルタレーション率 (eGFR) に基づいているが,リスク層分化のプロテイン尿を統合していない.
  • タンパク質尿は,CKD患者における有害な臨床結果と独立して関連しています.

研究 の 目的:

  • 減少したGFRとタンパク質尿と不良な臨床結果との組み合わせの関連性を調査する.
  • プロテイン尿が,一般成人集団におけるEGFRレベルに関連するリスクを変化させるかどうかを判断する.

主な方法:

  • カナダのアルバータ州で920,985人の成人を対象としたコミュニティベースのコホート研究 (2002年~2007年).
  • eGFRとプロテインウリア (尿検査棒またはアルバミン-クレアチニン比率 (ACR)) の測定のための使用された実験室の登録データ.
  • すべての原因による死亡率,心筋梗塞,腎不全の進行を含む評価されたアウトカム.

主要な成果:

  • 高濃度のタンパク質尿は,eGFRから独立して,全因死亡率,心筋梗塞,腎不全の増加と関連していました.
  • 濃度の高いタンパク質尿とeGFR ≥60mL/min/1.73m2を有する個人は,適度なeGFRとタンパク質尿のない個人に比べて死亡リスクが2倍以上であった.
  • ACRおよび末期性腎疾患などの他の不良結果についても同様の関連性が見られた.

結論:

  • タンパク質尿は,CKDにおける有害な結果の独立した予測因子です.
  • 死亡率,心筋梗塞,腎不全のリスクは,特定のeGFRでより高いタンパク質尿レベルによって増幅されます.
  • 臨床ガイドラインは,包括的なCKDリスク分層化のためのタンパク質尿の評価を組み込むことを検討する必要があります.